Deep Learning Reconstruction Algorithms in Dual Low-dose CTA
NCT ID: NCT06372756
Last Updated: 2024-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1200 participants
OBSERVATIONAL
2023-06-01
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computational Imaging Research Based on Deep Learning
NCT05471869
The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning
NCT07274436
Artificial Intelligent Image Processing and Diagnosis of Pulmonary Vessels in CT
NCT06589843
Application of Artificial Intelligence Deep Learning Technology in Magnetic Resonance Lumbar Imaging
NCT06037057
Deep Learning CAD Screening on Chest CT
NCT07181512
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Techniques such as filtered back projection, iterative reconstruction, and deep learning reconstruction were performed.
3. The feasibility of deep learning reconstruction in double low-dose CTA was evaluated based on image quality and diagnostic performance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard dose group
Raw data from 400 patients with conventional dose head and neck CTA, coronary CTA, and abdominal CTA were included. Filtered back-projection, iteration, and deep learning reconstruction were performed. To evaluate the impact of deep learning reconstruction on image quality and diagnostic performance in patients with conventional dose CTA.
Deep learning image reconstruction
Deep learning image reconstruction (DLIR) is a newly developed artificial intelligence noise reduction algorithm in recent years. It trains massive high-quality FBP data sets to learn to distinguish noise and signal, so as to selectively reduce noise and reconstruct high-quality images with low-quality image data.
Double low dose group
Raw data from 800 patients with low tube voltage and contrast medium head and neck CTA, coronary CTA, and abdominal CTA were included. Filtered back-projection, iteration, and deep learning reconstruction were performed. To evaluate the impact of deep learning reconstruction on image quality and diagnostic performance in patients with double-low-dose CTA.
Deep learning image reconstruction
Deep learning image reconstruction (DLIR) is a newly developed artificial intelligence noise reduction algorithm in recent years. It trains massive high-quality FBP data sets to learn to distinguish noise and signal, so as to selectively reduce noise and reconstruct high-quality images with low-quality image data.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Deep learning image reconstruction
Deep learning image reconstruction (DLIR) is a newly developed artificial intelligence noise reduction algorithm in recent years. It trains massive high-quality FBP data sets to learn to distinguish noise and signal, so as to selectively reduce noise and reconstruct high-quality images with low-quality image data.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hao Tang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hao Tang
associate chief physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hao Tang, Doctor
Role: PRINCIPAL_INVESTIGATOR
Tongji Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
102122
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.